This is consistent with in vitro findings that IL-4-treated microglia are potentially more efficient phagocytes [33], as well as an in vivo finding in which elevated Arg1 and reduced iNOS mRNA correlated with greater Aβ microglial phagocytosis and reduced amyloid plaque load [30]. This evidence concerns the gene ARG1 and amyloidosis.